Proud to fund research initiatives to help kids with cancer.

Pre-clinical development of novel immune therapy for paediatric cancers
Pre-clinical development of novel immune therapy for paediatric cancers
Recipient: Dr Alla Dolnikov
Institute: Sydney Children's Hospital, Randwick
Funding: $480,000 July 2016 to June 2022
Impact of treatment on late effects and survivorship on childhood cancer survivors
Impact of treatment on late effects and survivorship on childhood cancer survivors
Institute: University of Sydney
Recipient: Professor Natasha Nassar
Funding: $39,578 July 2019 to June 2021
Developing treatments for vincristine-induced neuropathy
Developing treatments for vincristine-induced neuropathy
Recipient: Associate Professor Irina Vetter
Institute: The University of Queensland
Funding: $255,978 July 2019 to June 2021
Development of a non-invasive diagnostic and prognostic assay for adolescent testicular cancer
Development of a non-invasive diagnostic and prognostic assay for adolescent testicular cancer
Recipient: Dr Cassy Spiller
Institute: The University of Queensland
Funding: $50,000 July 2019 to June 2021
Epigenetic targeted therapy in DIPG
Epigenetic targeted therapy in DIPG
Recipient: Associate Professor David Ziegler
Institute: Children’s Cancer Institute
Funding: $251,428 July 2019 to June 2021
MicroRNA drugs for the treatment of neuroblastoma
MicroRNA drugs for the treatment of neuroblastoma
Recipient: Associate Professor Alexander Swarbrick
Institute: Garvan Institute of Medical Research
Funding: $308,270 July 2018 to June 2021
The NORTH Trial
The NORTH Trial
Recipient: Dr Paul Wood
Institute: ANZCHOG
Funding: $61,420 July 2018 to June 2021
National Tumour Biobanking Network
National Tumour Biobanking Network
Recipient: Professor Jennifer Byrne and Rose Boutros
Funding: $482,891 July 2015 to June 2021
3D printers and mini-brains
3D printers and mini-brains
Recipient: Associate Professor Geraldine O’Neill
Institute: The Children’s Hospital at Westmead
Funding: $119,821 July 2019 to June 2020
Overcoming therapeutic resistance in high risk ALL using novel BH3 mimetic combinations
Overcoming therapeutic resistance in high risk ALL using novel BH3 mimetic combinations
Recipient: Dr Diane Hanna
Institute:The Walter and Eliza Hall Institute
Funding: $100,000 July 2019 to June 2020
Using targeted chemotherapies to reduce intensity of radiotherapy in medulloblastoma
Using targeted chemotherapies to reduce intensity of radiotherapy in medulloblastoma
Recipient: Dr Nick Gottardo
Institute: Telethon Kids Institute
Funding: $256,342 July 2018 to June 2020
New therapies for incurable paediatric brain tumours
New therapies for incurable paediatric brain tumours
Recipient: Professor Brandon Wainwright
Institute: The Institute of Molecular Bioscience
Funding: $224,936 July 2018 to June 2020
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Recipient: Dr Rishi Kotecha
Institute: Telethon Kids Institute
Funding: $445,695 July 2017 to June 2020
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Recipient: Professor Richard Lock
Institute: Children’s Cancer Institute
Funding: $103,571 July 2017 to June 2020
Ready, Steady, School
Ready, Steady, School
Recipient: Dr Joanna Fardell
Institute: UNSW Australia
Funding: $523,308 July 2016 to June 2020
Science is the solution for kids with cancer
The only way to improve outcomes for children diagnosed with cancer is through advances in medical research. Every day and every donation takes us closer to a cure.
Select your donation details
Please enter the amount you would like to donate

The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581